Ligand Pharmaceuticals LGND Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's short-term investments?
- Ligand Pharmaceuticals (LGND) reported short-term investments of $664.33M in Q1 2026.
- How has Ligand Pharmaceuticals's short-term investments changed year-over-year?
- Ligand Pharmaceuticals's short-term investments increased by 312.9% year-over-year, from $160.91M to $664.33M.
- What is the long-term trend for Ligand Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's short-term investments has grown at a 9.0% compound annual growth rate (CAGR), from $363.57M to $558.59M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.